Taiwanese Biotech Tops 3 IPOs Totaling $46M In Short Week

A Taiwanese biotechnology company raised nearly $22 million after pricing a downsized U.S. initial public offering on Wednesday, represented by Cooley LLP and K&L Gates LLP, concluding an abbreviated Thanksgiving week...

Already a subscriber? Click here to view full article